Skip to main content
. 2021 May 1;7(5):357. doi: 10.3390/jof7050357

Table 3.

Capacity of the host hospitals’ laboratories to perform antifungal susceptibility testing (AFST) and therapeutic drug monitoring (TDM) and information about reference to external laboratories.

Unit Capacity of the Host Hospital’s Laboratory Refers to An External Laboratory Type of Laboratory of Reference
AFST TDM * AFST TDM * AFST TDM *
1 Only yeasts No Yes (moulds) Yes Private Private
2 Only yeasts No Yes (moulds) Yes University University, Other Hospital, Private
3 Yes No No Yes - University, Private
4 Yes No No No - -
5 Yes No Yes (if necessary) Yes University University
6 Yes No No Yes - Private
7 Yes No No Yes - University, Private
8 Yes Yes No No - -

* The laboratories’ ability for TDM concerns mainly voriconazole, posaconazole and occasionally itraconazole and 5-FC.